Summary
- Current Price
- As of today, VVOS price is $0.73, up +4.85% on
- Current Price All-Time High
- VVOS price is currently -99.80% below its historical high of $360.25 set on
- Market Cap
- VVOS current market cap is $10M, down -46.15% year-over-year
- PE Ratio
- VVOS PE ratio is unknown
- Revenue
- VVOS current annual revenue is $17.44M, up +16.05% year-over-year
- Next Earnings
- The next earnings release for VVOS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Vivos Therapeutics, Inc. |
| Ticker | NASDAQ: VVOS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vivos.com |
| Employees | 113 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.73 | ||
| Price, 1D Change | +4.85% | |
| $10M | ||
| - | ||
| - | ||
| 0.73 | ||
| $17M | ||
| Revenue, 1Y Change | +16.05% | |
| -$2.06 | ||
| EPS, 1Y Change | +7.11% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.06 | ||
| EPS Estimate | N/A | -$1.15 |
| EPS Est. Change | N/A | +44.03% |
| $17.44M | ||
| Revenue Estimate | N/A | $23.27M |
| Revenue Est. Change | N/A | +33.38% |
| $0.73 | ||
| Price Target | - | $2.50 |
| Price Tgt. Change | - | +244.26% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.79 | -$2.22 | -23.93% | |
| -$2.03 | -$2.06 | -1.67% | |
| -$1.15 | N/A | +44.03% | |
| -$0.35 | N/A | +83.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $15.20M | $15.03M | -1.12% | |
| $20.71M | $17.44M | -15.77% | |
| $23.27M | N/A | +33.38% | |
| $39.48M | N/A | +126.31% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -76.87% | ||
| -91.14% | ||
| -46.15% | ||
| +1.45% | ||
| +16.05% | ||
| +8.86% | ||
| +7.11% | ||
| +92.05% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.73 | ||
| $2.37 | ||
| SMA 200 vs Price | +226.63% | |
| $1.11 | ||
| SMA 50 vs Price | +52.18% | |
| 0.73 | ||
| $0.09 | ||
| 32.82 | ||
| 75.99% | ||
| 93.67% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $17.44M | ||
| -$2.06 | ||
| $9.23M | ||
| 52.93% | ||
| -$19.89M | ||
| -114.05% | ||
| -$21.23M | ||
| -121.71% | ||
| -$18.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -9.06 | ||
| 0.24 | ||
| 0.24 | ||
| - | ||
| 2 | ||
| -9.32 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.57 | ||
| -6.68 | ||
| -1.15 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$1.49M | ||
| $2.03M | ||
| $25.15M | ||
| $4.38M | ||
| $26.70M | ||
| $18.08M | ||
| $13.50M | ||
| $9.08M | ||
| $1.68M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $38.61M | ||
| $29.13M | ||
| $8.21M | ||
| $0.00 | ||
| $1.31M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$15.26M | ||
| -$7.53M | ||
| $18.56M | ||
| $2.34M | ||
| -$17.60M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | ||
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Alliance Global Partners | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital |
Analyst sentiment
Institutional ownership
Screeners with VVOS
FAQ
What is the ticker symbol for Vivos Therapeutics, Inc.?
The ticker symbol for Vivos Therapeutics, Inc. is NASDAQ:VVOS
Does Vivos Therapeutics, Inc. pay dividends?
No, Vivos Therapeutics, Inc. does not pay dividends
What sector is Vivos Therapeutics, Inc. in?
Vivos Therapeutics, Inc. is in the Healthcare sector
What industry is Vivos Therapeutics, Inc. in?
Vivos Therapeutics, Inc. is in the Medical Devices industry
What country is Vivos Therapeutics, Inc. based in?
Vivos Therapeutics, Inc. is headquartered in United States
When did Vivos Therapeutics, Inc. go public?
Vivos Therapeutics, Inc. initial public offering (IPO) was on December 11, 2020
Is Vivos Therapeutics, Inc. in the S&P 500?
No, Vivos Therapeutics, Inc. is not included in the S&P 500 index
Is Vivos Therapeutics, Inc. in the NASDAQ 100?
No, Vivos Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Vivos Therapeutics, Inc. in the Dow Jones?
No, Vivos Therapeutics, Inc. is not included in the Dow Jones index
When was Vivos Therapeutics, Inc. last earnings report?
Vivos Therapeutics, Inc.'s most recent earnings report was on November 19, 2025
When does Vivos Therapeutics, Inc. report earnings?
The next expected earnings date for Vivos Therapeutics, Inc. is May 14, 2026
Data Sources & References
- VVOS Official Website www.vivos.com
- VVOS Profile on Yahoo Finance finance.yahoo.com/quote/VVOS
- VVOS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vvos